Zhejiang Canaan Technology Past Earnings Performance
Past criteria checks 0/6
Zhejiang Canaan Technology's earnings have been declining at an average annual rate of -46.7%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 7.3% per year.
Key information
-46.7%
Earnings growth rate
-47.3%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 7.3% |
| Return on equity | -4.2% |
| Net Margin | -2.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Zhejiang Canaan Technology Limited's (SZSE:300412) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Oct 01
Revenues Working Against Zhejiang Canaan Technology Limited's (SZSE:300412) Share Price Following 28% Dive
Jun 12Zhejiang Canaan Technology Limited (SZSE:300412) Surges 42% Yet Its Low P/S Is No Reason For Excitement
Mar 08Revenue & Expenses Breakdown
How Zhejiang Canaan Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,132 | -31 | 217 | 86 |
| 30 Jun 24 | 1,122 | -28 | 218 | 85 |
| 31 Mar 24 | 1,066 | -38 | 223 | 83 |
| 31 Dec 23 | 1,047 | -23 | 220 | 84 |
| 30 Sep 23 | 1,112 | -90 | 228 | 85 |
| 30 Jun 23 | 1,087 | -101 | 220 | 89 |
| 31 Mar 23 | 1,093 | -85 | 213 | 85 |
| 01 Jan 23 | 1,103 | -75 | 206 | 80 |
| 30 Sep 22 | 1,065 | 54 | 183 | 73 |
| 30 Jun 22 | 1,122 | 78 | 178 | 71 |
| 31 Mar 22 | 1,102 | 81 | 170 | 69 |
| 01 Jan 22 | 1,060 | 74 | 166 | 67 |
| 30 Sep 21 | 1,155 | 73 | 162 | 66 |
| 30 Jun 21 | 1,103 | 77 | 165 | 58 |
| 31 Mar 21 | 1,089 | 72 | 164 | 53 |
| 31 Dec 20 | 1,007 | 68 | 158 | 50 |
| 30 Sep 20 | 948 | 70 | 160 | 49 |
| 30 Jun 20 | 849 | 61 | 141 | 51 |
| 31 Mar 20 | 716 | 54 | 138 | 48 |
| 31 Dec 19 | 703 | 51 | 142 | 49 |
| 30 Sep 19 | 621 | 40 | 137 | 43 |
| 30 Jun 19 | 578 | 35 | 131 | 36 |
| 31 Mar 19 | 577 | 34 | 128 | 36 |
| 31 Dec 18 | 579 | 34 | 125 | 33 |
| 30 Sep 18 | 483 | 27 | 130 | 29 |
| 30 Jun 18 | 483 | 37 | 123 | 37 |
| 31 Mar 18 | 463 | 40 | 124 | 29 |
| 31 Dec 17 | 445 | 44 | 122 | 24 |
| 30 Sep 17 | 390 | 58 | 103 | 15 |
| 30 Jun 17 | 339 | 55 | 105 | 0 |
| 31 Mar 17 | 310 | 56 | 94 | 0 |
| 31 Dec 16 | 302 | 57 | 90 | 0 |
| 30 Sep 16 | 249 | 56 | 73 | 0 |
| 30 Jun 16 | 239 | 56 | 67 | 0 |
| 31 Mar 16 | 230 | 54 | 64 | 0 |
| 31 Dec 15 | 217 | 51 | 59 | 0 |
| 30 Sep 15 | 207 | 47 | 55 | 0 |
| 30 Jun 15 | 208 | 48 | 52 | 0 |
| 31 Mar 15 | 200 | 45 | 50 | 0 |
| 31 Dec 14 | 184 | 43 | 46 | 0 |
| 30 Sep 14 | 180 | 46 | 38 | 0 |
| 31 Dec 13 | 154 | 35 | 35 | 0 |
Quality Earnings: 300412 is currently unprofitable.
Growing Profit Margin: 300412 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300412 is unprofitable, and losses have increased over the past 5 years at a rate of 46.7% per year.
Accelerating Growth: Unable to compare 300412's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300412 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).
Return on Equity
High ROE: 300412 has a negative Return on Equity (-4.17%), as it is currently unprofitable.